Otter Pharmaceuticals, LLC completed the acquisition of certain worldwide assets used in the operation of the OTREXUP from Antares Pharma, Inc..
Otter Pharmaceuticals, LLC entered into an agreement to acquire certain worldwide assets used in the operation of the OTREXUP from Antares Pharma, Inc. (NasdaqCM:ATRS) for $44 million on December 15, 2021. As per the terms of the transaction, $18 million shall be paid at closing, $16 million, payable on May 31, 2022 and $10 million to be paid on December 15, 2022, the one-year anniversary of the closing date.
Otter Pharmaceuticals, LLC completed the acquisition of certain worldwide assets used in the operation of the OTREXUP from Antares Pharma, Inc. (NasdaqCM:ATRS) on December 15, 2021.